Street Calls of the Week
Investing.com -- Kemira reported third-quarter 2025 results that aligned with market expectations, leading to a 2.5% increase in its share price.
The company’s adjusted EBITDA decreased by 7% year-over-year to €137 million in Q3 2025. This figure matched analyst estimates of €137 million and was nearly 1% above the consensus expectation of €136 million.
Kemira’s adjusted EBITDA margin declined by 30 basis points year-over-year to 20.0% in the third quarter, compared to analyst estimates of 19.8% and consensus projections of 19.5%.
Revenue fell by 5.5% year-over-year to €687.7 million in Q3 2025, slightly below analyst estimates of €692 million and consensus expectations of €700 million.
Operating profit saw a 13% year-over-year decrease to €87.8 million in the third quarter, marginally below analyst projections but in line with broader market expectations.
The company’s reported earnings per share dropped by 7% year-over-year to €0.38 in Q3. Both analysts and consensus had projected €0.39 per share, with the difference attributed to higher-than-anticipated special items.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.